HHS launches new model for ambulatory services to serve outside the ED

HHS and the Center for Medicare and Medicaid Innovation introduced a new payment model for emergency ambulance services aimed at getting fee-for-service beneficiaries the appropriate level of care at a lower cost.

The new model––dubbed the ET3 model, for Emergency Triage, Treat and Transport––encourages the development of medical triage lines for low-acuity 9-1-1 calls. Participating ambulance supplies and providers can earn up to a 5 percent payment adjustment in the later years of the model if they hit key quality measures.

Specifically, it allows participating ambulance suppliers to deliver treatment options, including on the scene or telehealth. Medicare beneficiaries that use 9-1-1 services can also be taken to alternative destination sites, such as urgent care clinics or primary care doctors’ offices following a medical emergency.

“This model will create a new set of incentives for emergency transport and care, ensuring patients get convenient, appropriate treatment in whatever setting makes sense for them,” HHS Secretary Alex Azar said in a statement. “Today’s announcement shows that we can radically rethink the incentives around care delivery even in one of the trickiest parts of our system. A value-based healthcare system will help deliver each patient the right care, at the right price, in the right setting, from the right provider.”

Through these changes, the ET3 model will test two ambulance payments in addition to paying for emergency transport to a hospital emergency department. Currently, Medicare primarily pays for transportation to a hospital ED for beneficiaries, even if another treatment option is more appropriate.

Medicare will pay for treatment in place with a qualified healthcare practitioner, on-the-scene or using telehealth. The program will also pay for emergency transport of Medicare beneficiaries to other destinations beyond the hospital, such as 24-hours care clinics, that aren’t currently covered by regulations.

The model is expected to start in 2020 with a five-year performance period. Participating providers and suppliers are also encouraged to partner with Medicaid agencies to boost access to model interventions.

CMS will release a request for applications in summer 2019 to solicit Medicare-enrolled ambulance suppliers and providers.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.